We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+15.58%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.42B
AUM Growth
+$102M
Cap. Flow
-$464M
Cap. Flow %
-13.58%
Top 10 Hldgs %
31.6%
Holding
114
New
35
Increased
21
Reduced
22
Closed
30

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$96M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$87.8M
3
AAPL icon
Apple
AAPL
+$79.1M
4
BIIB icon
Biogen
BIIB
+$75.7M
5
NOW icon
ServiceNow
NOW
+$63M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$112M
2
AMAT icon
Applied Materials
AMAT
+$90.5M
3
ABBV icon
AbbVie
ABBV
+$61.7M
4
ALDR
Alder Biopharmaceuticals
ALDR
+$57.6M
5
MSFT icon
Microsoft
MSFT
+$52.5M

Sector Composition

Rank Sector Weight
1 Healthcare 36.89%
2 Technology 12.36%
3 Communication Services 7.79%
4 Consumer Discretionary 7.19%
5 Energy 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGNX icon
76
Regenxbio
RGNX
$610M
$4.02M 0.12%
+287,239
New +$3.17M
DMTX
77
DELISTED
Dimension Therapeutics, Inc
DMTX
$3.56M 0.1%
446,003
-220,067
-33% -$1.59M
SNDA icon
78
Sonida Senior Living
SNDA
$2.03B
$1.93M 0.06%
+7,638
New +$2.02M
AMAT icon
79
CALL
Applied Materials
AMAT
$382B
– –
-2,409,300
Closed -$57.8M
AMAT icon
80
Applied Materials
AMAT
$382B
– –
-3,777,487
Closed -$90.5M
AR icon
81
Antero Resources
AR
$10.4B
– –
-1,753,495
Closed -$45.6M
BDX icon
82
Becton Dickinson
BDX
$45.5B
– –
-239,012
Closed -$39.5M
BMY icon
83
CALL
Bristol-Myers Squibb
BMY
$130B
– –
-1,830,300
Closed -$135M
BMY icon
84
Bristol-Myers Squibb
BMY
$130B
– –
-519,722
Closed -$33.4M
CBRE icon
85
CBRE Group
CBRE
$43.4B
– –
-1,762,886
Closed -$46.7M
HAL icon
86
Halliburton
HAL
$26.3B
– –
-892,964
Closed -$40.4M
HOLX
87
DELISTED
Hologic
HOLX
– –
-1,175,350
Closed -$40.7M
INVA icon
88
Innoviva
INVA
$1.6B
– –
-133,897
Closed -$1.41M
JAZZ icon
89
CALL
Jazz Pharmaceuticals
JAZZ
$16.4B
– –
-204,700
Closed -$28.9M
LIVN icon
90
LivaNova
LIVN
$4.5B
– –
-244,851
Closed -$12.3M
LLY icon
91
PUT
Eli Lilly
LLY
$1.09T
– –
-1,089,700
Closed -$85.8M
MCK icon
92
McKesson
MCK
$102B
– –
-281,238
Closed -$52.5M
MRK icon
93
PUT
Merck
MRK
$326B
– –
-2,506,921
Closed -$138M
MSFT icon
94
Microsoft
MSFT
$2.95T
– –
-1,026,566
Closed -$52.5M
OEF icon
95
PUT
iShares S&P 100 ETF
OEF
$19.9B
– –
-109,400
Closed -$28.2M
PBYI icon
96
Puma Biotechnology
PBYI
$398M
– –
-1,471,879
Closed -$43.8M
QQQ icon
97
CALL
Invesco QQQ Trust
QQQ
$447B
– –
-527,600
Closed -$56.7M
THC icon
98
Tenet Healthcare
THC
$21.9B
– –
-691,461
Closed -$19.1M
UHS icon
99
Universal Health Services
UHS
$9.74B
– –
-249,510
Closed -$33.5M
VRTX icon
100
Vertex Pharmaceuticals
VRTX
$123B
– –
-135,487
Closed -$11.7M
1 2 3
4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2016 Portfolio in Review

As of Q3 2016, PFM Health Sciences held 114 positions worth $3.42B, up 3.1% from $3.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences withdrew a net $464M in Q3 2016, closing 30 positions and reducing 22 holdings. Its most notable exit was Aetna Inc, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 39% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Union Pacific worth $100M.

  • PFM Health Sciences's largest Q3 2016 buy was Union Pacific: 1,026,981 shares worth $100M.
  • PFM Health Sciences added most to Jazz Pharmaceuticals in Q3 2016, an estimated $87.8M increase.
  • PFM Health Sciences's biggest Q3 2016 reduction was AbbVie, cutting an estimated $61.7M.
  • PFM Health Sciences fully exited Aetna Inc in Q3 2016, selling an estimated $112M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.42B portfolio in Q3 2016.
  • PFM Health Sciences opened 35 new positions and closed 30 in Q3 2016.
  • PFM Health Sciences's portfolio value rose 3.1% quarter-over-quarter to $3.42B.

Based on PFM Health Sciences's 13F filing for Q3 2016, filed 14 Nov 2016.